Inventor · disambiguated record
Xiaolan Zheng
Also filed as: ZHENG XIAOLAN
9 granted patents·18 pending applications·21 citations·filing 2005–2025
82Inventor score
Top patents by PatentIndex Score
27 records- 0192US11795158B2Chemical compoundsASTRAZENECA AB·Filed 2021·Granted Oct 24, 2023·3 cites·4 claims
- 0284US8901307B2Chemical compounds 251DAKIN LESLIE·Filed 2009·Granted Dec 2, 2014·15 cites·5 claims
- 0377US12421208B2Chemical compoundsASTRAZENECA AB·Filed 2023·Granted Sep 23, 2025·0 cites·9 claims
- 0476US7723337B23-cinnolinecarboxamide derivatives and their use for treating cancerASTRAZENECA AB·Filed 2008·Granted May 25, 2010·3 cites·11 claims
- 0576US2025368615A1Chemical compoundsASTRAZENECA AB·Filed 2025·Application pending·0 cites
- 0669US11472816B2Mcl-1 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2020·Granted Oct 18, 2022·0 cites·9 claims
- 0767US10889594B2MCL-1 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2018·Granted Jan 12, 2021·0 cites·10 claims
- 0860US2025214995A1Condensed bicyclic heteroaromatic compounds and their use in the treatment of cancerASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 0959US10196404B2MCL-1 inhibitors and methods of use thereofASTRAZENECA AB·Filed 2017·Granted Feb 5, 2019·0 cites·4 claims
- 1057US2024116926A1Heteroaromatic compoundsASTRAZENECA AB·Filed 2023·Application pending·0 cites
- 1155US2009099210A1Enantiomers of selected fused heterocyclics and uses thereofASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1254US2008153854A1Novel fused heterocycles and uses thereofASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1351US7498333B2Enantiomers of selected fused heterocyclics and uses thereofASTRAZENECA AB·Filed 2005·Granted Mar 3, 2009·0 cites·4 claims
- 1449US11149024B2Synthesis of Mcl-1 inhibitorASTRAZENECA AB·Filed 2018·Granted Oct 19, 2021·0 cites·2 claims
- 1549US2015051185A1Chemical Compounds 251ASTRAZENECA AB·Filed 2014·Application pending·0 cites
- 1649US2022267356A1Arginase inhibitors and methods of use thereofASTRAZENECA AB·Filed 2020·Application pending·0 cites
- 1749US2009270450A1Chemical compoundsASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 1848US2009054411A14-anilinoquinoline-3-carboxamides as csf-1r kinase inhibitorsASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 1947US2010311748A1Heterocyclic amides useful for the treatment of cancer and psoriasisASTRAZENECA AB·Filed 2008·Application pending·0 cites
- 2045US2006063751A1Novel fused heterocycles and uses thereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2145US2008293744A1Enantiomers of Selected Fused Pyrimidones and Uses in the Treatment and Prevention of CancerASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2243US2008312206A1Chemical Compounds-149ASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2341US2011098283A13-cinnolinecarboxamide derivatives and their use for treating cancerASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 2441US2008306096A1Quinazoline Derivatives, Process for Their Preparation and Their Use as Anti-Cancer AgentsASTRAZENECA AB·Filed 2006·Application pending·0 cites
- 2539US2009118261A1Quinazolinone derivatives and their use as b-raf inhibitorsASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2638US2006041128A1Selected fused heterocyclics and uses thereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
- 2735US2007249636A1Selected Fused Heterocyclics and Uses ThereofASTRAZENECA AB·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaolan Zheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →